chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine leaked from the injection site. Due to the patient's fear of needles the dose was repeated subcutaneously into the left arm. No injuries, or physical adverse events occured.
On 2/5/2021, I went to doctors' office. They told me I had a blood clot, and they prescribed me with Xarelto 15mg 2x day.
This spontaneous report was received from a nurse refers to a patient of unknown demographics. No relevant medical history was reported. On 04-MAR-2014, the patient was in office to receive a third dose of GARDASIL (dose and route of administration were not provided). No concomitant medications were reported. On 04-MAR-2014, the patient was a month late for the third dose of GARDASIL. The exact dates of first and second doses of GARDASIL were unspecified. No adverse event was reported. Additional information has been requested.
Does have a mental illness problem, bipolar manic depression.; COPD; cough; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Every COVID-19 vaccine she ever got caused her to cough but she has COPD.), for COVID-19 Immunization, reaction(s): "COPD", "Cough". The following information was reported: BIPOLAR I DISORDER (medically significant), outcome "unknown", described as "Does have a mental illness problem, bipolar manic depression."; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (non-serious), outcome "recovered", described as "COPD"; COUGH (non-serious), outcome "recovered".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient noted bruising of arm on side of HPV vaccine administration but not directly of site of injection. Bruising lasted 4-5 days.
Lost 50% of left hand and finger strength If I am  cold while working  outside or in garage, another 25% of strength is lost. And finger dexterity is greatly decreased.  I have very light trembling or vibration from shoulder to tips of fingers. The above continue unchanged every day. Extreme fatigue all day on some days, moderate fatigue all other days
Fussy for 30 minutes, took three hours to calm him. More spitting up.
This spontaneous report as received from a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX vial (route, dosage, dose number and lot number unknown). On an unknown date the patient developed a rash after receiving the ZOSTAVAX. Additional information is not expected.
Day after injection, all body bone pain and lethargy. Four days later full body rash. After a few weeks, began right sided thoracic level intermittent pain over right kidney area with a mild itchy rash. Had three different hospital clinic work ups: ultrasound for kidney stones, Xrays of spine, and MRI of spine. On fourth visit to see oncologist for possible MGUS progression, Dr. diagnosed the pain as =Dermatome pain. This had been suggested by PCP and Physical Therapist, but thought to be unlikely with no live virus in SHINGRIX vaccine.
Hot flash about 20 minutes after shot, numb lips, redness of neck face and ears, itching, tightness in throat. I took two 2 Benadryl and called my Dr. Then went to ER @ 9:10. I was given an IV 50 mg Benadryl , steroid injection, pepcid injection, injection of  epinephrine. Heart Rate got up to 118. Let hospital with medications Benadryl 1 cap 3 x a day, Prednisone 1-2 tabs daily.
Mild symptoms I had with my second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Mild symptoms I had with my second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Mild symptoms I had with my second shot). At the time of the report, VACCINATION COMPLICATION (Mild symptoms I had with my second shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported. No treatment drug details was reported.
15 mo. imm. given on 07-09-13 at WCE. First report of s/s by parents to office on 8-15-13. S/S = (Rt) thigh edema; 'moderate' size soft lump without warmth, redness, tenderness. (No VAERS report sent - mgr. not informed). Developed granuloma; now with 2.8 x 3.7 cm seroma req. sx drainage and POCS excision on 02-18-14.
sore arm; feeling tired; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (feeling tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Contrast media allergy. Concomitant products included VITAMIN D3 and FISH OIL for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (feeling tired). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 mg; METHYLPREDNISOLONE at a dose of 16 mg and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 650 mg. At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (feeling tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-089522 (Patient Link).
Received the shot at 2:10.  2:15, she was feeling light headed and tingly sensation in her extremities. She didn't let anyone know at this time.  The person observing her noticed she seemed  zoned out and asked how she was doing at about 2:17 and learned that her tingliness was  turning into numbness of  extremities focused on her upper body.  She started displaying other symptoms of a minor panic attack.  We monitored her for the full 30 minutes, had her walk around, drink water, etc. She claimed that while her numbness wasn't getting better, it also wasn't getting worse. It was starting to itch though, so she was given some benedryl.  She then went home for the evening where her roommate could monitor her.   Next day, she called in to confirm that her numbness/itchiness had turned into a rash on her chest which has disappeared. But now is experiencing diarrhea, headache, weakness and dizziness.  She was informed that these symptoms were within the normal range of immune responses, but that if she was too miserable, she could go in to urgent care for medical assistance. She declined to do so at that time (approximately 11:45 am).
This spontaneous case, initially received from a pharmacist on 24-Sep-2018, concerning a 61-year-old, adult patient of an unspecified gender. The patient's medical history and concomitant medications were not available. Since 03-Sep-2018, the refrigerator's temperature fluctuated above 47F and FLUCELVAX QIVc vaccine exposed to temperatures in the range of 47F to 50.9F. On 07-Sep-2018, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location, batch number and expiry date: not reported] which underwent temperature excursion. The patient did not experience any adverse drug reaction after the vaccination. The reporter assessed the case as non-serious. This case 201804083 cross-linked to original case 201804076 due to the same reporter. Non-significant follow-up received from the reporter on 14-Nov-2018: Added Med info number (SEQ18-04086) in the additional information tab. No changes were made in the narrative.
On 03/06/2023, I started to feel bad. On 03/07/2023 and 03/08/2023, I tested positive on COVID-19 tests. On 03/08/2023, I started PAXLOVID. I had loss of taste, fever, fatigue, I lost 12 pounds.
pt recv vax & devel a 6cm by 6cm area of swelling & inflammation @ inj site;the next day pt felt ill;tx w/motrin & ice;
Pt called this evening reporting arm pain in her armpit area that started this morning. Pt also has some red spots at the site of the Band Aid and higher up on the arm from where the vaccine was given. Pt has full range of motion, but arm hurts with movement. Pt has taken some ibuprofen and will monitor and use ibuprofen or APAP as needed for pain. Pt will call again or follow-up with MD if loses range of motion or reaction worsens where she is concerned.
his whole thigh was swollen; his whole thigh was hard; his whole thigh was hot; his whole  thigh was red; the office documented it was given subcutaneously but it was actually given intramuscularly; there was a little bit of hard knot; This spontaneous report has been received from the consumer, referring to her son, a 4 years old male patient. The patient did not have any medical history, current conditions, concomitant medications, drug reactions or allergies.  On 14-JUN-2019, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) one syringe, intramuscularly instead of subcutaneously on the top of his thigh, with lot number S000623 and expiration date on 06-JUL-2020, for prophylaxis (strength was not provided) (Incorrect route of product administration). It was also reported the sterile diluent for vaccine reconstitution, administered intramuscularly (strength, dose frequency, indication, lot number and expiration date were not reported).  In approximately June 2019, the patient initially had a little bit of a hard knot (Injection site nodule). Then, on 16-JUN-2019, when he woke up on the morning, his hole thigh was red (Erythema), hot (Feeling hot), swollen (Peripheral swelling), and hard (Induration). At beginning, his mother wondered if there was something wrong with this batch, but later she decided that her son's reaction was due to the inadvertently administration intramuscularly rather than subcutaneously. On an unknown date, the mother would take him to see the doctor. It was not reported if the patient received any treatment or if any laboratory or study were performed.  At the time of the report, the patient had not recovered from the events. The causality assessment between Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) and the aforementioned events was not reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA007443: US-009507513-1906USA007270: US-009507513-1906USA007149:
I got the vaccine on Monday for first responders. Everything was fine besides the routine ape was in my left arm. About 1030 last night, I was standing at my fireplace and started to rub my arm where I got the vaccine. That?s the last thing I remember. My wife said as I was walking towards the bed and went completely stiff and fell backwards on our floor. She said my eyes were wide open and I wasn?t breathing. I started to come too while she was on the phone with 911. My body felt very heavy and I couldn?t really feel anything. Cotton mouth and shaking very badly. I was taken to the hospital and spent the night there. All test came back good. Today I feel really lethargic and foggy.  I find it very suspicious that immediately after I rubbed my arm that I passed out. My wife thought I was dead, I didn?t know what happened.  I?m in shape and workout 4-5 days a week and am very active. I feel it is important to report this adverse reaction. This has never happened before to any other vaccines.
Beginning approximately 11 hours post injection, headache (mild). Headache persisted throughout the day and then approximately 22 hours post injection, general feeling of malaise, feeling cold, feeling like I was running a fever (temporal thermometer read 98.8 degrees) and basically feeling ill began and has persisted since that time. Took naproxyn OTC, Benadryl, and nasal spray listed in meds earlier and went to bed.
little bumps on back, shoulder, and hips; This case was reported by a nurse via call center representative and described the occurrence of rash in a 66-year-old female patient who received Herpes zoster (Shingrix) (batch number KR7G2, expiry date 2nd June 2021) for prophylaxis.   On 24th April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but it could be 65 or 66 years. The patient developed little bumps on her back, shoulder, and hips.
I am writing to learn whether or not symptoms that I am experiencing post my Pfizer Covid-19 vaccines, which were both given to me on my left arm have been reported.  Post my second vaccine I had experienced some tenderness in my left arm which lasted more than 3 days.  They eventually left.  However, in early July, 2021.  I began to experience during my workouts some weakness on my left arm from shoulder, down my arm.  I continued to work out assuming that it would strengthen itself at some point.  I went to see my primary care doctor, on or about 11/04/ 21 and informed her of my concern.  She recommended an x-ray of my shoulder.  On 11/5/21, I went to Orthopedics and met with PA who did the shoulder x-ray, and referred me for a Stat MRI of my spine, which I had done on 11/5/21.  I was referred by PA  to a spine surgeon at the Orthopedic Office.  Dr. performed some reflex tests, went over my MRI and informed me that he would be referring me to a neurologist from Neurology Office.   I met with Dr. 2 weeks ago and yesterday we had a follow up.  I have nerve damage in my left arm, and am now being referred to Hospital.
This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received SHINGRIX for prophylaxis. On 2nd August 2018 02:00, the patient received the 2nd dose of SHINGRIX. On 2nd August 2018, less than a day after receiving SHINGRIX, the patient experienced fever. In August 2018, the patient experienced headache, lethargy, tiredness and influenza-like symptoms. On an unknown date, the outcome of the fever, headache, lethargy, tiredness and influenza-like symptoms were unknown. It was unknown if the reporter considered the fever, headache, lethargy, tiredness and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter was patient's husband, he reported that the patient might have started having a fever overnight, but she had one at the time of reporting which was 101 degrees. He said she was having the same side effects you might have like flu like symptoms.
Patient states he felt tightness in his chest and redness/swelling that began around the injection site and continued to the hand.
received COVID booster vac on Friday 3/4, states has n/v/diarrhea, HA. rash on back, fever, joint pains, leg numbness, and metal taste in mouth. She states she did a VARES report after 2nd dose.  She is stating that after she received the booster that she is experiencing today a low grade fever of 99.6Overall, her sxs are "getting better". No numbess in the legs, but tingling is present. diarrhea is going, now mild "queeziness". +HA, +low grade fever, +Metal taste in mouth, +rash
Gave Meningococcal  B, OMV instead should of give  Meningococcal  Polysaccharide (Groups A, C, Y, W-135)  TT Conjugate.  The Pt did not have any adverse reaction to the Vaccine.
No adverse event; 4 doses were administered past the expiration date. Lot number unknown. Expiration date: 12Jul2023 Administration date: 13Jul2023.; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 doses were administered past the expiration date. Lot number unknown. Expiration date: 12Jul2023 Administration date: 13Jul2023.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Jul-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 doses were administered past the expiration date. Lot number unknown. Expiration date: 12Jul2023 Administration date: 13Jul2023.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 doses were administered past the expiration date. Lot number unknown. Expiration date: 12Jul2023 Administration date: 13Jul2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (4 doses were administered past the expiration date. Lot number unknown. Expiration date: 12Jul2023 Administration date: 13Jul2023.).    No concomitant information was reported. Suspect product dosage text was reported as unknown. The expiry date was reported as 12-Jul-2023.  No treatment information was provided. This case is reported for patient 4 out of 4 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-733816 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-733816:Master case (patient 1)
I had significant chest pain and burning across my chest and back the night of shot one. That persisted for weeks. It happened again but at a lesser degree with shot two. I also had a very hard time with physical exertion for months post vaccine. Finally I was sent in for an echo cardiogram and my heart was okay but the hypothesis is that there was likely myocarditis that went untreated based on the symptoms that I experienced.
I was working at and, around 5:30 am when I felt some strong pain both side of my chest.  Sonner I felt a slight headache and from time to time it intensified to become unsupportable. At that time though about a lack of oxygenation, because I wore mask for the whole time I was working. About 9:am when I drove to home, I saw everything foggy in front of me.  When I get home I took  some paracetamol and another painkiller, because at that time my entire body was so warm, and the headache was very bad. I slept for 5 hours, when I woke up I went to the mechanic to fix my car.  While I got back during the time I saw the same foggy vision.
warmth at injection site; rash around the hand; fever; rash at injection site; swelling at injection site; arm began feeling sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm began feeling sore), VACCINATION SITE WARMTH (warmth at injection site), RASH (rash around the hand), PYREXIA (fever) and VACCINATION SITE RASH (rash at injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A210A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (arm began feeling sore). On 13-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warmth at injection site), RASH (rash around the hand), PYREXIA (fever), VACCINATION SITE RASH (rash at injection site) and VACCINATION SITE SWELLING (swelling at injection site). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain and Fever, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. On 13-Mar-2021, PYREXIA (fever) had resolved. On 14-Mar-2021, RASH (rash around the hand) had resolved. At the time of the report, PAIN IN EXTREMITY (arm began feeling sore) had not resolved and VACCINATION SITE WARMTH (warmth at injection site), VACCINATION SITE RASH (rash at injection site) and VACCINATION SITE SWELLING (swelling at injection site) outcome was unknown.            No relevant concomitant medications were provided. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-015296 (Patient Link).
Patient received a Moderna vaccine Booster, 0.25ml, from a vial that was opened for more than 12 hours.  The vial was opened on 5/6/22 at 0900.  The patient was notified and returned to the office for another booster dose from a newly opened vial.